![]() |
![]() |
![]() |
|
Vol. 9, No. 1-24, pp. 1-808 Jan. 6, 2010 - Dec. 15, 2010 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
ILLINOIS
– Newborn screening, 84
– Stem cell research grants, 254
– Clinical trials, new restrictions, 111
– Alzheimer's trial database, 374
– Clinical research and IT investment, 110 – E-health
See E-HEALTH
– Northrop Grumman IT research, 175 – Safety Report Portal, FDA-NIH announce, 345 – Stem cell treatments, website, 375 – Univ. of Louisville clinical trial website breach, 381
– Accuracy of forms at issue, 372
– AMA resolution, 411 – Cal. emergency exemption, 457 – Cancer center forged signatures, 565 – Comprehension of forms, 518 – Coroner's retaining body part without consent of family (Cal. Ct. App.), 412 – Decisionally impaired subjects, applicable state laws, 258 – Eye implant, noneconomic damage cap (S.D. Ohio), 400 – Genetic research issues, 618 – Havasupai tribe and Ariz. State Univ., 444; HHS panel examines, 501 – HIPPA, proposed changes, 441; agency support, 702 – Mishandling body parts
– – Andre suit, no duty to families (Cal. Ct. App.), 562
– – Waters and Cohen suits, no duty to families (Cal. Ct. App.), 252 – Opting out of health data collection, 789 – Posting of forms online suggested, 687 – Specific language, FDA proposed rule, 19 – Stent implant claims (3rd Cir.), 167 – Third-party gamete donor consent, 140 – Translated consent forms, 489 – U.K. unauthorized tissue and organ removal, 763
– Fla. rules, 26
– Grants from NIH, 80 – Guidance
– – Conflicts of interest, NIH rules, 667
– – Draft guidance from FDA, 42 – – FAQs from OHRP, 209 – – Finalized guidance expected from OHRP, 187; final guidance issued, 784 – Protection of study subjects, data sought, 583 – Public access to reviews, 22
– Academic Inventors' Bill of Rights, 213
– Fabrazyme shortage, 551 – International developments, genetics and biodiversity, 691 – Malaria product development partnership, 521 – Patents
See PATENTS
– Technology transfer, House hearing, 364 – Traditional knowledge and folklore, WIPO initiative, 521 – University ownership and Bayh-Dole, 651 – Written description requirement (Fed. Cir.), 203
– Clinical trials, foreign study data usage, 417
– HIV international patent pool, 613 – Intellectual property, genetics, and biodiversity, 691 – Traditional knowledge and folklore, WIPO initiative, 521
– Informed consent, posting of forms online suggested, 687
– Cancer clinical trial coverage mandate, 146
– Epicor use by Ankeny, Iowa, workers, 729 – Genetic discrimination ban signed, 287
– Investigational drug, access (N.D.N.Y.), 695
Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |